These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22796822)

  • 1. Pacing-facilitated proarrhythmia.
    Tsikrikas S; Bramos D; Kollias G; Letsas KP; Efremidis M; Sideris A
    Hellenic J Cardiol; 2012; 53(4):327-8. PubMed ID: 22796822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?
    Sweeney MO; Ruetz LL; Belk P; Mullen TJ; Johnson JW; Sheldon T
    J Am Coll Cardiol; 2007 Aug; 50(7):614-22. PubMed ID: 17692746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular pacing induced ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Roelke M; O'Nunain S; Osswald S; Trouton TG; Harthorne JW; Garan H; Ruskin JN
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 1):486-91. PubMed ID: 7770372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Delayed detection of ventricular tachycardia due to intradevice interactions by implantable atrio-ventricular pacer/cardioverter defibrillator.
    Kantharia BK; Padder FA
    J Interv Card Electrophysiol; 2006 Aug; 16(2):135-8. PubMed ID: 17016683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late dofetilide-associated life-threatening proarrhythmia.
    Kolb C; Ndrepepa G; Zrenner B
    Int J Cardiol; 2008 Jul; 127(2):e54-6. PubMed ID: 17588691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hazards of antitachycardia pacing to treat ventricular tachycardias with implantable cardioverter defibrillators.
    Maass AH; Van Gelder IC
    Europace; 2009 Jun; 11(6):819. PubMed ID: 19357140
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of ICD shock burden by eliminating back-up pacing induced ventricular tachyarrhythmias.
    Theis C; Mollnau H; Sonnenschein S; Konrad T; Himmrich E; Bock K; Schulz E; Kämpfner D; Gerhardt S; Quesada Ocete B; Münzel T; Rostock T
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):889-895. PubMed ID: 24654876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia.
    Ridley DP; Gula LJ; Krahn AD; Skanes AC; Yee R; Brown ML; Olson WH; Gillberg JM; Klein GJ
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):601-5. PubMed ID: 15946356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a mechanistic link between atrial fibrillation and vulnerability to ventricular arrhythmias?
    Rashba EJ; Estes Iii NA
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1253-5. PubMed ID: 21806695
    [No Abstract]   [Full Text] [Related]  

  • 15. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection.
    Shivkumar K; Feliciano Z; Boyle NG; Wiener I
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1285-8. PubMed ID: 11083251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transesophageal ventricular stimulation and ventricular tachycardia in the period before implantation of a cardioverter-defibrillator].
    Pella J; Bodnár J; Stancák B; Misíkoá S; Sedlák J; Cizmárik P
    Vnitr Lek; 1994 Oct; 40(10):663-6. PubMed ID: 7810086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICD proarrhythmia as a consequence of an interaction with an algorithm to prevent atrial arrhythmias.
    Martínez-Sánchez J; García-Alberola A; Sánchez-Muñoz JJ; Peñafiel-Verdú P; Giner-Caro JA; Valdés-Chávarri M
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1096-8. PubMed ID: 19659632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to avoid inappropriate therapies due to ventricular double detection in biventricular pacing implantable cardioverter/defibrillators.
    Kolb C; Zrenner B; Schreieck J; Schmitt C
    Eur J Heart Fail; 2003 Aug; 5(4):523-6. PubMed ID: 12921814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.
    Swerdlow CD; Chen PS; Kass RM; Allard JR; Peter CT
    J Am Coll Cardiol; 1994 May; 23(6):1342-55. PubMed ID: 8176092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.